SCHEMBL7744772

SCHEMBL7744772

CC(=O)Nc1oc(-c2ccccc2-c2cccc(O)c2)nc1-c1ccsc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 7/20 0.61
FLT4 P35916 2/20 0.55
FLT1 P17948 1/20 0.55
ABL1 P00519 1/20 0.43
ALOX15 P16050 1/20 0.43
ADORA3 P0DMS8 1/20 0.39
ADORA2A P29274 1/20 0.39
MAPK8 P45983 1/20 0.39
MAPK9 P45984 1/20 0.39
CSNK2A1 P68400 1/20 0.39
DYRK1A Q13627 1/20 0.39
AURKB Q96GD4 1/20 0.39
PRKD2 Q9BZL6 1/20 0.39
FABP4 P15090 1/20 0.38
FYN P06241 2/20 0.38
ESRRG P62508 2/20 0.37
S1PR4 O95977 1/20 0.37
ESR1 P03372 1/20 0.36
ESR2 Q92731 1/20 0.36
TOP2A P11388 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7744668 0.88 KDR (0.69) KDRFLT4FLT1ABL1ALOX15
SCHEMBL7746570 0.88 KDR (0.49) KDRFLT4FLT1FABP4ESRRG
SCHEMBL7744076 0.86 KDR (0.46) KDRFLT4FLT1ADORA3ADORA2A
SCHEMBL7744200 0.85 KDR (0.53) KDRFLT4FLT1ABL1ALOX15
SCHEMBL7739080 0.84 KDR (0.62) KDRFLT4FLT1ABL1ALOX15
SCHEMBL7739089 0.84 KDR (0.60) KDRFLT4FLT1ABL1ALOX15
SCHEMBL7739016 0.83 KDR (0.56) KDRFLT4FLT1ABL1ALOX15
SCHEMBL7981129 0.83 KDR (0.55) KDRFLT4FLT1ALOX15ADORA3
SCHEMBL7746642 0.82 KDR (0.55) KDRFLT4FLT1ABL1ALOX15
SCHEMBL7744664 0.82 KDR (0.55) KDRFLT4FLT1ABL1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP claimed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP claimed
US-6228871-B1 THIAZOLE OR OXAZOLE DERIVATIVE TYROSINE KINASE INHIBITORS; ANTICARCINOGENIC AGENTS; AUTOIMMUNE DISEASES; DIABETIC RETINOPATHY MERCK & CO., INC. 2001-05-08 US claimed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO claimed
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP disclosed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP disclosed
US-6228871-B1 THIAZOLE OR OXAZOLE DERIVATIVE TYROSINE KINASE INHIBITORS; ANTICARCINOGENIC AGENTS; AUTOIMMUNE DISEASES; DIABETIC RETINOPATHY MERCK & CO., INC. 2001-05-08 US disclosed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO disclosed